Movement Disorders

Merely having the technical ability to perform functional neurosurgery is not sufficient. An understanding of key clinical concepts surrounding movement disorders lies at the heart of becoming a competent functional neurosurgeon in order to ensure correct patient selection and perioperative management. This chapter provides a thorough medical overview of the fundamental clinical aspects, including pathophysiology, diagnosis and medical therapy for the commonest movement disorders encountered in neurosurgical practice: Parkinson’s disease, essential tremor, and dystonia. A brief overview of the surgical management options and outcomes from surgery is discussed. Finally, some of the controversies related to the surgical aspects of movement disorders are examined.

• Publication year

  1998

• Venue

  Stereotactic and Functional Neurosurgery

• Publication date

  1998-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000029607PMID 9780408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1.

  2000cited by this paper
• The DYT1 phenotype and guidelines for diagnostic testing

  2000cited by this paper
• A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.

  2000cited by this paper
• Botulinum toxin in the treatment of tics.

  2000cited by this paper
• A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

  2000cited by this paper
• Motor disorder in Huntington's disease begins as a dysfunction in error feedback control

  2000cited by this paper
• Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus

  1999cited by this paper
• Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus

  1999cited by this paper
• Progressive Dystonia in a Child With Chromosome 18p Deletion, Treated With Intrathecal Baclofen

  1999cited by this paper
• Differential Diagnosis of Parkinsonism

  1999cited by this paper
• Expression of the early‐onset torsion dystonia gene (DYT1) in human brain

  1998cited by this paper
• Pallidal activity during dystonia: somatosensory reorganisation and changes with severity

  1998cited by this paper
• Intrathecal baclofen in the treatment of dystonic storm

  1998cited by this paper
• Course of Tic Severity in Tourette Syndrome: The First Two Decades

  1998cited by this paper
• Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.

  1997cited by this paper
• High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor

  1997cited by this paper
• Intrathecal baclofen for severe torsion dystonia in a child

  1996cited by this paper
• Selective elimination of cerebellar output in the genetically dystonic rat.

  1995cited by this paper
• Functional connectivity in the motor cortex of resting human brain using echo‐planar mri

  1995cited by this paper
• Intrathecal baclofen for motor disorders

  1995cited by this paper
• Post‐traumatic movement disorders

  1994cited by this paper
• Premonitory urges in Tourette's syndrome.

  1993cited by this paper
• Thalamic stimulation and proximal tremor. A specific target in the nucleus ventrointermedius thalami.

  1993cited by this paper
• Hereditary Dystonia Overview

  1993cited by this paper
• Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus.

  1992cited by this paper
• Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging.

  1992cited by this paper
• Clonidine treatment of Gilles de la Tourette's syndrome.

  1991cited by this paper
• Intrathecal baclofen for intractable axial dystonia

  1991cited by this paper
• Paroxysmal dystonic head tremor

  1991cited by this paper
• Neural mechanisms of dystonia: Evidence from a 2‐deoxyglucose uptake study in a primate model of dopamine agonist‐induced dystonia

  1990cited by this paper
• Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.

  1990cited by this paper
• The Gilles de la Tourette Syndrome: the Current Status

  1989cited by this paper
• The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.

  1989cited by this paper
• Idiopathic dystonia among ashkenazi jews: Evidence for autosomal dominant inheritance

  1989cited by this paper
• Epidemiology of focal and generalized dystonia in Rochester, Minnesota

  1988cited by this paper
• Clonidine and Gilles de la Tourette's syndrome: Double‐blind study using objective rating methods

  1987cited by this paper
• Movement Disorders

  1986cited by this paper
• The anatomical basis of symptomatic hemidystonia.

  1985cited by this paper
• Stereotaxic thalamotomy in 55 cases of dystonia.

  1983cited by this paper
• Gilles de la Tourette's syndrome: Cross-cultural analysis and treatment outcome

  1974cited by this paper
• Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis.

  1974cited by this paper
• The Neurophysiological Correlates of Motor Tics following Focal Striatal Disinhibition

  year unknowncited by this paper
• diagnostic and statistical manual of mental disorders,

  year unknowncited by this paper

• Dualsteric and dual-acting modulation of muscarinic receptors by antagonist KH-5

  2026cites this paper
• Serum Myeloperoxidase Activity Is Associated with Hoehn‐Yahr Staging and Striatal Dopamine‐Transporter Binding in Parkinson's Disease

  2025cites this paper
• Human Pose Estimation Is Approximate: Limitations and Considerations for Its Use in Clinical Trials

  2025cites this paper
• The Influence of Genetics in the Early Development of Axial Postural Abnormalities in Parkinson's Disease

  2025cites this paper
• Natural History and Progression of Dentatorubral–Pallidoluysian Atrophy (DRPLA): A Retrospective Study of 22 Patients

  2025cites this paper
• Pitfalls in the Diagnosis of Wilson Disease

  2025cites this paper
• Food—Consistency/Texture—Specific Pharyngeal Dystonia: A Novel Form of Focal Task‐Specific Dystonia

  2025cites this paper
• Мiryachit: A Culture‐Specific Startle Syndrome in the Saami People

  2025cites this paper
• Cognitive Fluctuation Scale in Non‐demented Patients with Parkinson's Disease

  2025cites this paper
• Effects of Levodopa on Gait in People With Parkinson's Disease With and Without a History of Falls

  2025cites this paper
• Clinical and Biomechanical Factors in the Sit‐to‐Stand Decline in Parkinson's Disease

  2025cites this paper
• Deep brain stimulation (DBS) in movement disorders management: exploring therapeutic efficacy, neurobiological mechanisms, and clinical implications

  2025cites this paper
• A Systematic Approach to Evaluating and Addressing Disparities in Deep Brain Stimulation

  2025cites this paper
• Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease

  2025cites this paper
• Long‐Term Outcome of Unilateral Magnetic Resonance Imaging–Guided Focused Ultrasound for Fragile X Tremor Ataxia Syndrome

  2025cites this paper
• Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis

  2025cites this paper
• FBXO7 Pathogenic Variants in Early‐Onset Parkinsonism: Insights from a Neuroimaging Perspective and Review of the Literature

  2025cites this paper
• Investigation of the Determinants of Disease Severity in Patients with Idiopathic Normal Pressure Hydrocephalus

  2025cites this paper
• Predictors of Loneliness in Parkinson's Disease and Craniocervical Dystonia

  2025cites this paper
• Clinical Phenotype and Neuroimaging Findings in Siblings with COX15 Deficiency: Case Report and Review of Previously Reported Cases

  2025cites this paper
• Developing an Outpatient Transdisciplinary Functional Movement Disorder Program: 1‐Year Experience

  2025cites this paper
• Parkinsonism and Dystonia Are Prevalent and Concomitant Movement Disorders in a Cohort of Patients with Rett Syndrome

  2025cites this paper
• Biological Characterization of the Anti-ferroptotic Properties of a Novel Anti-Parkinsonian Iron (II) Selective Dopamine Agonist, D-583

  2025cites this paper
• Belly Dancer's Dyskinesia or Functional Movement Disorder: Involuntary Abdominal Movements in a Pediatric Patient

  2025cites this paper
• Parkinsonism‐Hyperpyrexia Syndrome Following Deep Brain Stimulation Battery Depletion during the COVID‐19 Pandemic: A Case Series and Review of the Literature

  2025cites this paper
• Stimulation‐Induced Dyskinesia in STN DBS Patients

  2025cites this paper
• A Pragmatic Approach to Sexual Health in Movement Disorders

  2025cites this paper
• Unmasking the Unexpected: FIG4‐Related Disorder Presenting with Progressive Supranuclear Palsy‐Like Features

  2025cites this paper
• Correlations between Dysphagia Severity Scale Scores and Clinical Indices in Individuals with Multiple System Atrophy

  2025cites this paper
• Hereditary Spastic Paraplegia in Alberta: Lessons from a Well‐Defined Cohort Including the Indigenous Population

  2025cites this paper
• A 69‐Year‐Old Male with Subacute Gait Disturbance—Blastocystis hominis Causing Extensive Colitis with Thiamine Deficiency

  2025cites this paper
• Video Urodynamic Study in Patients with Parkinson's Disease and Multiple System Atrophy

  2025cites this paper
• Bridging Clinical Expertise and Digital Innovation: Toward a Modern Phenomenology of Parkinsonism

  2025cites this paper
• Hyperkinetic movement disorder analysis using multidimensional projections

  2025cites this paper
• Using a Brief Body Sway Assessment Device to Track Balance Differences across the Huntington's Disease Integrated Staging System Spectrum

  2025cites this paper
• Clinical response to placebo botulinum toxin injection in cervical dystonia—a systematic review and meta-analysis

  2025cites this paper
• A Review of Treatment Methods for Movement Disorders.

  2025cites this paper
• Prevalence and Types of Chronic Pain among Insured Individuals with Tic Disorders

  2025cites this paper
• Huntington's Disease‐Like 2 in a European Caucasian Patient

  2025cites this paper
• Diagnostic Utility of Clinical Neurophysiology in Jerky Movement Disorders: A Review from the MDS Clinical Neurophysiology Study Group

  2024cites this paper
• Atypical Presentations of Huntington Disease‐like 2 in South African Individuals

  2024cites this paper
• Levodopa‐Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5‐Year Follow‐Up Study

  2024cites this paper
• Assessment and Treatment of Abnormal Involuntary Movements: A Clinically Focused Narrative Review

  2024cites this paper
• Changes in Caregiver Burden Following Unilateral Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy for Essential Tremor

  2024cites this paper
• Ears of the Lynx on Neuroimaging in a Patient with COQ4‐Associated Hereditary Spastic Paraplegia

  2024cites this paper
• A Stroke With Pride and Prejudice: A Case Report

  2024cites this paper
• Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology

  2024cites this paper
• Vibrotactile Foot Device for Freezing of Gait in Parkinson's Disease: A Pilot Study

  2024cites this paper
• Examining Agreement in Psychotic Symptom Assessment: Insights from Parkinson's Disease Dementia Dyads

  2024cites this paper
• Avoiding Premature Diagnostic Closure: Lessons from Two Children with Neurotransmitter Disorders Associated with Dual Pathology

  2024cites this paper
• Two aspects of feed-forward control of action stability: effects of action speed and unexpected events

  2024cites this paper
• Directional deep brain stimulation electrodes in Parkinson’s disease: meta-analysis and systematic review of the literature

  2024cites this paper
• Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives

  2024cites this paper
• We Hope You're Listening: Qualitative Study of Advice Given by Individuals with Parkinson's Disease

  2024cites this paper
• Widening the Phenotype of Fragile‐X Tremor Ataxia Syndrome in Females: Spasmodic Dysphonia in Two Patients

  2024cites this paper
• Pick's Disease Presenting as Tremulous Parkinsonism with Limited Levodopa Response—A Rare Cause of Corticobasal Syndrome

  2024cites this paper
• Sex Differences in Dystonia

  2024cites this paper
• Rehabilitation for Functional Dystonia: Cases and Review of the Literature

  2024cites this paper
• Decompression Surgery in Elderly Patients with Hemifacial Spasm Refractory to Botulinum Toxin

  2024cites this paper
• GBA1-Associated Parkinson’s Disease Is a Distinct Entity

  2024cites this paper
• Long‐Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled Study

  2024cites this paper
• Opicapone to Treat Early Wearing‐off in Parkinson's Disease Patients: The Korean ADOPTION Trial

  2024cites this paper
• Meta-analysis and review of rechargeable implantable pulse generators for spinal cord stimulation and deep brain stimulation

  2024cites this paper
• A Call for Change: Updating the Operational Definition for Dementia in Parkinson's Disease

  2024cites this paper
• Impulsivity Traits in Parkinson's Disease: A Systematic Review and Meta‐Analysis

  2023cites this paper
• Antiparkinsonian Medication Reconciliation as a Strategy to Improve Safety by Preventing Medication Errors

  2023cites this paper
• Real‐World Driving Data Indexes Dopaminergic Treatment Effects in Parkinson's Disease

  2023cites this paper
• A Complex Pattern of Involuntary Movements Following Infection by Tick‐Borne Encephalitis Virus of Western/European Variant, Single Case Report

  2023cites this paper
• Ataxia due to a COQ8A Novel Variant in Primary Coenzyme Q10 Deficiency

  2023cites this paper
• Dystonic Tremor Disappearance after Internal Capsule Stroke

  2023cites this paper
• Copper Deficiency as a Serious Complication of Anti‐Copper Treatment in Wilson's Disease

  2023cites this paper
• Late Presentation of Chronic Traumatic Encephalopathy in a Former Association Football Player

  2023cites this paper
• Intermittent Ultralow‐Frequency Low‐Amplitude Deep Cerebellar Stimulation for Movement Disorders

  2023cites this paper
• Olanzapine Liquisolid Tablets Using Kolliphor EL with Improved Flowability and Bioavailability: In vitro and In vivo Characterization

  2023cites this paper
• The Role of Supplements and Over-the-Counter Products to Improve Sleep in Children: A Systematic Review

  2023cites this paper
• Meropenem‐Induced Facial Myoclonus

  2023cites this paper
• Molecular mechanisms of neurodegenerative disease (NDD)

  2023cites this paper
• THAP1 Associated Dystonia: An NBIA Mimic

  2023cites this paper
• Incorporating Consciousness into an Understanding of Emotion and Nonverbal Behavior

  2023cites this paper
• Structural insight into G2019S mutated LRRK2 kinase and brain-penetrant type I inhibitor complex: a molecular dynamics approach

  2023cites this paper
• Clinical Characteristics and Outcomes in Young‐Onset Multiple System Atrophy

  2023cites this paper
• Punding in Parkinson's Disease: An Update

  2023cites this paper
• Sex Differences in the Therapy of Advanced Movement Disorders

  2023cites this paper
• Alternating unilateral blepharospasm with apraxia of eyelid opening in a patient with progressive supranuclear palsy

  2023cites this paper
• Case‐Fatality Rate in Parkinson's Disease: A Nationwide Registry Study

  2023cites this paper
• Intronic FGF14 GAA repeat expansions are a common cause of downbeat nystagmus syndromes: frequency, phenotypic profile, and 4-aminopyridine treatment response

  2023cites this paper
• Reply to: Pregabalin Responsive Tongue and Arm Tremor after Guillain Barré Syndrome

  2023cites this paper
• Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases

  2023cites this paper
• A Study of Dopaminergic Pathway in Neurologic Wilson Disease with Movement Disorder

  2023cites this paper
• [Restless sleep disorder a new entity to considered in children].

  2023cites this paper
• Proposal of Period Modulation Control of Wearable Cyborg HAL Trunk-Unit for Parkinson's Disease/Parkinsonism Utilizing Motor Intention and Dynamics

  2023cites this paper
• Striatal CDK5 Regulates Cholinergic Neuron Activation and Dyskinesia-like Behaviors through BK Channels

  2023cites this paper
• Cough Correlates of Functional Swallow Outcomes in Atypical Parkinsonism

  2023cites this paper
• Clinical and Neurophysiological Features of Orthostatic Myoclonus in a Patient with IgLON5‐Disease: A Novel Presentation

  2023cites this paper
• Neurosurgical management of non-spastic movement disorders

  2023cites this paper
• Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia

  2023cites this paper
• The role of α-synuclein in Parkinson disease

  2023cites this paper
• Smelling the Disease: Diagnostic Potential of Breath Analysis

  2023cites this paper
• Eyelid Nystagmus and Other Involuntary Movements of the Upper Lids; What's in a Name?

  2023cites this paper
• Movement Disorders in PURA Syndrome: A Video Case Series

  2023cites this paper